Td Asset Management Inc Cara Therapeutics, Inc. Transaction History

Td Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$11.99 - $18.14 $232,606 - $351,916	-19,400 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$11.6 - $19.27 $2,320 - $3,854	200 Added 1.04%	19,400 $372,000
Q4 2017 Feb 02, 2018	SELL	$11.86 - $14.08 $4,744 - $5,632	-400 Reduced 2.04%	19,200 $235,000
Q3 2017 Nov 09, 2017	BUY	$12.6 - $16.34 $246,960 - $320,264	19,600	19,600 $268,000

16.5M

55K

500

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.1M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.